Submission

AMA submission on Government administration of the Pharmaceutical Benefits Scheme

The AMA opposes Government decisions to defer listing of medicines on the PBS that have been recommended by the independent Pharmaceutical Benefits Advisory Committee (PBAC). The Government is leaving itself open to accusations of political interference by ignoring the PBAC assessment and pricing process which is fair, equitable, evidence-based and transparent.

The AMA opposes Government decisions to defer listing of medicines on the PBS that have been recommended by the independent Pharmaceutical Benefits Advisory Committee (PBAC). The Government is leaving itself open to accusations of political interference by ignoring the PBAC assessment and pricing process which is fair, equitable, evidence-based and transparent.

Related Download

Related topics